The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Efmoroctocog alfa (rhu)

Australian Public Assessment Report

AusPAR

AusPAR: Efmoroctocog alfa (rhu) [PDF, 626.09 KB]

AusPAR: Efmoroctocog alfa (rhu) [Word, 814.04 KB]

Attachment: Product Information: Efraloctocog alfa (rhu) [PDF, 391.59 KB]

Attachment: Product Information: Efraloctocog alfa (rhu) [Word, 413.87 KB]

Attachment: Extract from the Clinical Evaluation Report: Efmoroctocog alfa (rhu) [PDF, 748.95 KB]

Attachment: Extract from the Clinical Evaluation Report: Efmoroctocog alfa (rhu) [Word, 1.69 MB]

Device/Product Name

Eloctate

Active ingredients

Efmoroctocog alfa (rhu)

AusPAR Date

17 March 2015

Published

7 April 2015

Submission Number

PM-2013-01157-1-4

Submission Type

New biological entity

Decision

Approved